phenobarbital has been researched along with salinomycin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bräuchle, C; Hermawan, A; Knyazev, P; Ljepoja, B; Mickler, FM; Roidl, A; Sommer, AK; Ullrich, A; Wagner, E | 1 |
1 other study(ies) available for phenobarbital and salinomycin
Article | Year |
---|---|
Salinomycin co-treatment enhances tamoxifen cytotoxicity in luminal A breast tumor cells by facilitating lysosomal degradation of receptor tyrosine kinases.
Topics: Biological Transport; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Drug Synergism; Endosomes; Estrogen Receptor alpha; Female; Humans; Inhibitory Concentration 50; Ligands; Lysosomes; MCF-7 Cells; Phenobarbital; Pyrans; Receptor Protein-Tyrosine Kinases; Selective Estrogen Receptor Modulators; Tamoxifen | 2016 |